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INTRODUCTION
Nonvariceal upper gastrointestinal bleeding (NVUGIB) is 
one of the most common reasons for hospitalization and a 
major cause of morbidity and mortality worldwide.1 Despite 
improvements in the management of this condition, the mor-
tality rate has remained unchanged, possibly due to a longer 
life expectancy and the corresponding higher number of co-
morbidities. International consensus recommendations on the 
management of patients with NVUGIB were published in 
2010.2 In addition, an Asia-Pacific working group produced its 
own consensus recommendations taking into account some 
regional characteristics of NVUGIB. These include a high 
prevalence of Helicobacter pylori infection and a potential dif-
ference in drug metabolism in Asia-Pacific populations as 
compared to other populations worldwide.3 Recently, new en-
doscopic devices and apparatuses have been used for endo-
scopic hemostasis along with the increasingly widespread 
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use of the endoscopic submucosal dissection (ESD) technique. 
In this review article, we will focus on the state of the art man-
agement of NVUGIB with a view to optimizing treatment ef-
ficacy for individual patients. 
PRE-ENDOSCOPIC MANAGEMENT
Patients presenting with upper gastrointestinal (GI) bleed-
ing are at risk of hemodynamic shock and airway compromise. 
The priority is to assess the adequacy of the airway and cir-
culation, and intravenous access should be secured with a 
large-bore cannula. Pulse oximetry, cardiac activity, and auto-
mated blood pressure measurements should also be moni-
tored. It is important to identify any use of nonsteroidal anti-
inflammatory drugs, anticoagulants such as warfarin, and 
antiplatelet medicines since these treatments can cause or ex-
acerbate upper GI bleeding. Coagulation time and hemoglo-
bin levels should be checked as well. All patients should also 
be blood typed and cross-matched for an appropriate num-
ber of units of packed red blood cells if necessary.4 Patients 
who have serious comorbid conditions may require hospital-
ization regardless of the severity of their bleeding.5 Existing 
well-validated scoring systems can help categorize patients 
with upper GI bleeding as having either a low or high risk of 
rebleeding and mortality. The most widely applied scoring sys-
tems are the Rockall and Blatchford scores.6,7 A primary aim 
Endoscopic Management of Nonvariceal Upper  
Gastrointestinal Bleeding: State of the Art
Naoki Muguruma, Shinji Kitamura, Tetsuo Kimura, Hiroshi Miyamoto and Tetsuji Takayama
Department of Gastroenterology and Oncology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima, Japan
Nonvariceal upper gastrointestinal (GI) bleeding is one of the most common reasons for hospitalization and a major cause of morbidity 
and mortality worldwide. Recently developed endoscopic devices and supporting apparatuses can achieve endoscopic hemostasis with 
greater safety and efficiency. With these advancements in technology and technique, gastroenterologists should have no concerns re-
garding the management of acute upper GI bleeding, provided that they are well prepared and trained. However, when endoscopic he-
mostasis fails, endoscopy should not be continued. Rather, endoscopists should refer patients to radiologists and surgeons without any 
delay for evaluation regarding the appropriateness of emergency interventional radiology or surgery.
Key Words:  Hemorrhage; Hemostasis; Equipment and supplies   
Open Access
Received: January 5, 2015    Accepted: January 17, 2015
Correspondence: Naoki Muguruma
Department of Gastroenterology and Oncology, Institute of Health Biosciences, 
The University of Tokushima Graduate School, 3-18-15, Kuramoto-cho, Tokushi-
ma 770-8503, Japan
Tel: +81-88-633-7124, Fax: +81-88-633-9235
E-mail: muguruma.clin.med@gmail.com
cc  This is an Open Access article distributed under the terms of the Creative 
Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
Print ISSN 2234-2400 / On-line ISSN 2234-2443
http://dx.doi.org/10.5946/ce.2015.48.2.96
FOCUSED REVIEW SERIES: 
Endoscopic Management of Upper Gastrointestinal Bleeding 




The hemoclip system is among the most popular endo-
scopic mechanical modalities for achieving hemostasis. Clips 
have also been applied to the closure of mucosal defects, fis-
tulas, and perforation holes.14 Endoscopic clips are deployed 
over a bleeding site including visible vessels and commonly fall 
off within days to weeks. If the bleeding site is located in the 
gastric fundus or the posterior wall of the duodenal bulb, ef-
fective hemoclipping is relatively difficult. The deployment of 
hemoclips on a hard or fibrotic ulcer base is often challenging.15 
Currently, hemoclip devices are rotatable and can be adjusted 
in the optimal direction by endoscopists. Hemoclips also 
come in various lengths, and shorter clips appear more effec-
tive on hard or fibrotic areas because they attach to these le-
sions more firmly than longer clips (Fig. 3A, B).16 Endoscopic 
band ligation devices, which have been used commonly for 
variceal bleeding, are also useful for treating NVUGIB by pro-
ducing mechanical compression.17 The hood-like device of 
the ligation kit, which applies suction to varices, is useful for 
clearly visualizing the bleeding point. However, the effective-
ness of this device depends on whether sufficient suction can 
be applied to a given lesion.
Cautery devices
Argon plasma coagulation (APC) is a noncontact thermal 
method whereby ionized argon gas delivers a monopolar elec-
trical current that effectively coagulates tissues. The most ad-
vantageous aspect of APC is its familiarity to the endoscopy 
unit in that endoscopists and nurses are able to employ this 
equipment in most situations, especially vascular ectasia and 
of such scoring systems is to determine whether the patient 
requires any urgent intervention, including endoscopy.4 After 
endoscopic evaluation, assessment by the full Rockall scoring 
system is recommended because endoscopic findings, includ-
ing adherent clots or visible vessels, can be combined with 
clinical factors to predict patients’ risk of rebleeding and mor-
tality. The Blatchford score is used to identify low-risk patients 
who do not require endoscopic intervention, although early 
endoscopy (within 24 hours of presentation) is recommended 
for most patients with acute upper GI bleeding. Some studies 
have shown that early endoscopy can decrease the length of 
patients’ hospital stays, but no additional benefits of urgent 
endoscopy (within 1 to 12 hours of presentation) have been 
shown in terms of reducing rebleeding, surgery, or mortali-
ty.8-11 A strategy algorithm for the treatment of NVUGIB is 
shown in Fig. 1.
ENDOSCOPIC MANAGEMENT
The Forrest classification is a method of stratifying upper 
GI hemorrhages into risk categories for mortality first pub-
lished by Forrest et al.12 in 1974. It has been widely used to 
select patients for endoscopic treatment and predict the risk 
of re-bleeding. With recent advancements in hemostatic de-
vices and agents, this classification continues to play an essen-
tial role in guiding treatment decisions (Fig. 2). Endoscopic 
hemostatic therapy is required for patients with hemorrhages 
classified as IA, IB, or IIA, although the necessity of endo-
scopic therapy for ulcers with adherent clots (IIB) is still de-
bated.13
Fig. 1. Strategy algorithm for the management of suspected upper gastrointestinal (GI) bleeding. EGD, esophagogastroduodenoscopy; 
PPI, proton pump inhibitor; CT, computed tomography.
Suspected upper GI bleeding
(hematemesis, tarry stool, coffee-ground-like emesis)
Initial assessment, resuscitation, pre-endoscopic management
(airway, volume replacement, blood transfusion, medication history, coagulopathy)
Perform EGD (urgent, elective)
No bleeding and low risk
Discontinue relevant medicine 
  medication with PPI
Helicobacter pylori eradication
No source found
Consider colonoscopy, small bowel  
  endoscopy, enhanced abdominal CT
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Fig. 2. Endoscopic features according to the Forrest classification. (A) Active spurting bleeding (IA). (B) Active oozing bleeding (IB). (C) No 
active bleeding with visible vessel (IIA). (D) Broad adherent clot (IIB). (E) Hematin-covered flat spots (IIC). (F) No bleeding stigmata with 







Fig. 3. Endoscopic hemostatic devices. (A) Injecting epinephrine solution into the base. (B) Mechanical clips with long arms (left) and short 
arms (right). (C) Clip deployment. (D) Argon plasma coagulation for active oozing from telangiectasia (square). (E) Grasping the bleeding 
vessel with coagulation forceps. (F) Successful burnout.
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oozing from superficial lesions. In APC, a flexible catheter 
passed through the working channel of the scope is placed 
against the target area, ideally in a vertical position. The press-
ing of a foot pedal then triggers a synchronized flow of argon 
gas and electrical current from the generator, producing tissue 
coagulation (Fig. 3C). The depth of cauterization is thought to 
be limited because the coagulated tissue will gain increased 
resistance to the current. Various catheter types and operation 
modes are available with the APC device, including forced, 
pulsed, and precise. The variables that determine the cauteriza-
tion effect can be set by endoscopists and nurses; these include 
the power setting (W), argon gas flow rate (L/min), distance 
to the tissue, and duration.18 In Korea and Japan, ESD has 
been widely performed for early gastric carcinoma, and the 
development of various hemostatic devices has accompanied 
its more widespread use. It has been reported that the use of 
hemostatic forceps together with soft coagulation is a safe 
and effective method of controlling upper GI ulcer bleeding 
(Fig. 3D, E).19 This type of device is preferred for the purpose 
of stopping spurting bleeding and ablating visible vessels.
Injection devices
Epinephrine injection is a common and effective method 
of achieving endoscopic hemostasis owing to its low risk, low 
cost, and simplicity (Fig. 3F). Epinephrine injection alone is 
superior to medical management alone, but is inferior to all 
other methods and should no longer be employed as a sole en-
doscopic treatment when other options are available.20 Other 
injectable agents such as thrombin, fibrin, cyanoacrylate glues, 
polidocanol, and ethanolamine are not commonly used in the 
treatment of NVUGIB.5 It should be kept in mind that arterial 
injection of adrenaline may cause severe hypertension dur-
ing emergency gastroscopy.21 The most commonly used injec-
tors have diameters of 23 or 25 G, while the needle length typi-
cally ranges from 3 to 5 mm. A special needle that is length-
adjustable between 2 and 7 mm is also available.
Supporting apparatuses
Water jet-equipped endoscope
Given the difficulty in identifying the bleeding point dur-
ing active bleeding, a water jet-equipped endoscope, which is 
widely used in ESD,22 is now indispensable for visualizing the 
‘culprit lesion’ in NVUGIB. This scope immediately washes 
away the blood flow, visualizing the target point during active 
hemorrhage (Fig. 4A, B) and removing adherent clots to ex-
pose the visible vessel underneath. Adding a small amount of 
the antifoaming agent simethicone to the water bottle helps 
prevent any hindrance from gas bubbles. This apparatus may 







Fig. 4. Supporting apparatuses for endoscopic hemostasis. (A) Active flowing bleeding. (B) Identifying the bleeding point with a waterjet. (C) 
Overtube. (D) Cap-mounted endoscope. (E) Visualization of exposed vessel with the cap. (F) Multibending scope with double working 
channels.
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tion to reducing operation times.
Carbon dioxide insufflators
A benefit of carbon dioxide (CO2) is its rapid absorption 
from the intestinal lumen into the blood stream. Thus, CO2 
insufflation during endoscopy can significantly decrease ab-
dominal pain and bloating both during and after the endo-
scopic procedure.23 CO2 insufflation is preferred for endoscop-
ic hemostasis procedures with a longer duration. CO2 use may 
permit the administration of lower doses of sedative medica-
tions, which is apparently safer for patients in critical condi-
tion, and can also lead to faster recovery times from high-de-
pendency care. However, CO2 insufflation may place patients 
with respiratory disorders, sleep apnea, morbid obesity, or 
known CO2 retention at risk of ventilator compromise. Thus, 
the use of conventional room air is preferred in these cases.23 
CO2 insufflation is beneficial in cases of perforation due to ex-
cessive electrocautery, although efforts must be made to avoid 
this complication.
Overtube
Aspiration pneumonia may occur in the setting of hemateme-
sis because of massive bleeding, and this may lead to mortali-
ty. An overtube is a sleeve-like device designed to facilitate en-
doscopy (Fig. 4C). All overtubes have an inner diameter that 
is larger than the diameter of an endoscope, providing a conduit 
for the passage of the device into the digestive tract.24 Overtubes 
limit the risk of aspiration during endoscopic hemostasis. They 
are also beneficial for repeated intubation and withdrawal in 
allowing adhered mucus or clots to be wiped off the endo-
scope lens. In certain cases, the bleeding vessel is located in 
either the upper gastric body or the gastric fornix, which may 
not be visible owing to a large amount of blood clots. In such 
cases, it is necessary to switch from the conventional observa-
tion position to the right lateral decubitus position. However, 
many endoscopists are uncomfortable using this reversed po-
sition when performing hemostasis. Mori and colleagues25 
(2013) invented an inverted overtube that can help endosco-
pists perform an emergency endoscopy in their conventional 
standing position relative to patients who are rotated to the 
right lateral decubitus position without changing the positions 
of the endoscopy unit and light source. This technique allows 
endoscopists to dislodge blood clots and food residue by grav-
ity and facilitates the rapid identification of exposed vessels, 
resulting in a higher rate of success for hemostasis.
Cap applicator
Endoscopic caps are commonly used in both diagnostic and 
therapeutic endoscopy, including mucosal resections. A vari-
ety of endoscopic caps are currently available in clinical prac-
tice, and they are effective when selected appropriately.26 It 
has been suggested that the application of a transparent cap to 
the tip of the endoscope can facilitate the approach to a tan-
gential angle and stabilize the lesion during hemostasis (Fig. 
4D, E).27 A non-randomized prospective study compared the 
success rates of achieving bleeding control using hemoclips with 
and without the aid of a transparent cap.28 In this study, hemo-
clipping with the cap allowed for the clipping of lesions that 
were situated too tangentially to be clipped without the use of 
the cap. Movements resulting from the patient’s rapid respira-
tion during emergency hemostasis often destabilize the posi-
tioning of the scope and hemostatic devices. In this frustrating 
situation, control can be achieved by pressing the cap against 
the lumen wall.
Multibending scope
Performing endoscopic hemostasis is challenging in certain 
locations such as the lesser curvature or posterior wall of the 
gastric body or the cardia and the lesser curvature of the an-
trum. A multibending scope (GIF-2T260M; Olympus Optical, 
Tokyo, Japan) (Fig. 4F) that provides a second flexible section 
for improved positioning capability was initially developed to 
facilitate endoscopic mucosal resection of gastric tumors in 
these locations.29 Using secondary flexion, the tip of the scope 
can reach substantially closer to lesions in difficult to reach lo-
cations. This special scope also has two working channels, al-
lowing for an efficient procedure whereby residual food or 
clots are removed by suction through one channel while a he-
mostatic device is inserted through the other channel.
LIMITATIONS OF ENDOSCOPIC  
MANAGEMENT 
Although endoscopic therapy usually achieves primary he-
mostasis, 10% to 30% of patients with NVUGIB have repeat 
bleeding.30-32 Patients in whom hemostasis is not achieved 
with endoscopy require transarterial embolization (TAE) or 
surgery. These are often elderly patients with multiple comor-
bidities who are poor candidates for emergency surgery.33 A 
large number of studies have proposed using TAE over sur-
gery as a salvage therapy; however, there is little empirical evi-
dence to support this recommendation.34,35 Rapid technologi-
cal advances in the management of NVUGIB have been made 
recently via interventional radiology, and prospective ran-
domized studies comparing the efficacy of TAE and radiolog-
ical interventions after failed endoscopic hemostasis are need-
ed. Optimal management requires a multidisciplinary team 
of skilled endoscopists, interventional radiologists, and GI sur-
geons who can integrate as a team promptly and effectively. 
In cases of failed endoscopic hemostasis in NVUGIB, endos-
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copy should not be continued and another treatment option 
should be decided upon without delay.
CONCLUSIONS
Many safe and effective devices are available for endoscopic 
hemostasis. With the existing advancements in technology 
and technique, gastroenterologists should have no concern re-
garding the management of acute upper GI bleeding, provided 
that they are well prepared and trained. However, when endo-
scopic hemostasis fails, endoscopy should not be continued. 
Rather, endoscopists should refer patients to radiologists and 
surgeons without delay for evaluation regarding the appropri-
ateness of emergency interventional radiology or surgery.
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